The role of immunomodulators on intestinal barrier homeostasis in experimental models

Clinical Nutrition

Volumn 34, Issue 6, 2015, Pages 1080-1087

  Andrade, Maria Emília Rabelo ^a   Araújo, Raquel Silva ^a   de Barros, Patrícia Aparecida Vieira ^a   Soares, Anne Danieli Nascimento ^a   Abrantes, Fernanda Alves ^a   Generoso, Simone de Vasconcelos ^a   Fernandes, Simone Odília Antunes ^a   Cardoso, Valbert Nascimento ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Amino acids; Fatty acids; Inflammation; Intestinal mucosa; Probiotics

Indexed keywords

AMINO ACID DERIVATIVE; ARGININE; CITRULLINE; FATTY ACID DERIVATIVE; GAMMA INTERFERON; GLUTAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; I KAPPA B ALPHA; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LINOLEIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; TRYPTOPHAN; CONJUGATED LINOLEIC ACID; IMMUNOLOGIC FACTOR;

APOPTOSIS; BACTERIAL VIABILITY; BIFIDOBACTERIUM; BIFIDOBACTERIUM INFANTIS; CELL MIGRATION; DIET SUPPLEMENTATION; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BREVIS; LACTOBACILLUS PLANTARUM; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUTRIENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; REVIEW; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; EPITHELIUM CELL; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; PERMEABILITY; SACCHAROMYCES;

ANIMALS; ARGININE; BIFIDOBACTERIUM; CITRULLINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FATTY ACIDS, OMEGA-3; GLUTAMINE; HOMEOSTASIS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LACTOBACILLUS; LINOLEIC ACIDS, CONJUGATED; PERMEABILITY; PROBIOTICS; SACCHAROMYCES; TRYPTOPHAN;

EID: 84924041331     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.01.012     Document Type: Review

References (50)

1. Ma T.Y., Anderson J.M., Turner J.R. Chapter 38: tight junctions and the intestinal barrier. Physiology of the gastrointestinal tract 2012, 1043-1088. Elsevier Academic Press, Burlington, MA. 5th ed. L.R. Johnson, F.K. Ghishan, J.D. Kaunitz, J.L. Merchant, H.M. Said, J.D. Wood (Eds.).
2. Costa K.A., Soares A.D.N., Wanner S.P., Santos R.G.C., Fernandes S.O.A.F., Martins F.S., et al. l-Arginine supplementation prevents increases in intestinal permeability and bacterial translocation in male Swiss mice subjected to physical exercise under environmental heat stress. J Nutr 2013, 144:1-6.
3. Viana M.L., Santos R.G.C., Generoso S.V., Nicoli J.R., Martins F.S., Nogueira-Machado J.A., et al. The role of l-arginine-nitric oxide pathway in bacterial translocation. Amino Acids 2013, 45:1089-1096.
4. Logan R.M., Stringer A.M., Bowen J.M., Gibson R.J., Sonis S.T., Keefe D.M.K. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?. Cancer Chemother Pharmacol 2009, 63:239-251.
5. Ghoshal U.C., Shukla R., Ghoshal U., Gwee K.A., Ng S.C., Quigley E.M. The gut microbiota and irritable bowel syndrome: friend or foe?. Int J Inflam 2012, published online Jan 7. 10.1155/2012/151085.
6. Manichanh C., Borruel N., Casellas F., Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012, 9:599-608.
7. Stringer A.M., Al-Dasooqi N., Bowen J.M., Tan T.H., Radzuan M., Logan R.M., et al. Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases. Support Care Cancer 2013, 21:1843-1852.
8. Thorpe D., Stringer A., Butler R. Chemotherapy-induced mucositis: the role of mucin secretion and regulation, and the enteric nervous system. Neurotoxicol Teratol 2013, 38:101-105.
9. Corthésy B. Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun Rev 2013, 12:661-665.
10. Yeoh A.S.J., Bowen J.M., Gibson R.J., Keefe D.M.K. Nuclear factor κB (NFκB) and cyclooxygenase-2 (COX-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int J Radiat Oncol 2005, 63:1295-1303.
11. Santos R.G., Quirino I.E., Viana M.L., Generoso S.V., Nicoli J.R., Martins F.S., et al. Effects of NO synthase inhibition on glutamine action in a bacterial translocation model. Br J Nutr 2014, 111:93-100.
12. Quirino I.E.P., Cardoso V.N., Santos R.G.C., Evangelista W.P., Arantes R.M.E., Fiúza J.A., et al. The role of L-arginine and inducible nitric oxide synthase in intestinal permeability and bacterial translocation. JPEN J Parenter Enteral Nutr 2013, 37:392-400.
13. Batista M.A., Nicoli J.R., Martins F.S., Machado J.A.N., Arantes R.M.E., Quirino I.E.P., et al. Pretreatment with citrulline improves gut barrier after intestinal obstruction in mice. JPEN J Parenter Enteral Nutr 2012, 36:69-76.
14. Vieira E.L., Leonel A.J., Sad A.P., Beltrão N.R.M., Costa T.F., Ferreira T.M.R., et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem 2011, 23:430-436.
15. Leonel A.J., Teixeira L.G., Oliveira R.P., Santiago A.F., Batista N.V., Ferreira T.R., et al. Antioxidative and immunomodulatory effects of tributyrin supplementation on experimental colitis. Br J Nutr 2013, 109:1396-1407.
16. Ferreira T.M., Leonel A.J., Melo M.A., Santos R.R.G., Cara D.C., Cardoso V.N., et al. Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids 2012, 47:669-678.
17. Generoso S.V., Viana M.L., Santos R.G., Martins F.S., Machado J.A.N., Arantes R.M.E., et al. Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol 2010, 192:477-484.
18. Generoso S.V., Viana M.L., Santos R.G., Arantes R.M.E., Martins F.S., Nicoli J.R., et al. Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. Eur J Nutr 2011, 50:261-269.
19. Kim C.J., Kovacs-Nolan J.A., Yang C., Archbold T., Fan M.Z., Mine Y. l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Nutr Biochem 2009, 21:468-475.
20. Wang W.W., Qiao S.Y., Li D.F. Amino acids and gut function. Amino Acids 2009, 37:105-110.
21. Weitzel L.R., Wischmeyer P.E. Glutamine in critical illness: the time has come, the time is now. Crit Care Clin 2010, 26:515-525.
22. Mondello S., Galuppo M., Mazzon E., Domenico I., Mondello P., Carmela A., et al. Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut. Eur J Pharmacol 2010, 643:304-315.
23. Li Y., Chen Y., Zhang J., Zhu J.F., Liu Z.J., Liang S.Y., et al. Protective effect of glutamine-enriched early enteral nutrition on intestinal mucosal barrier injury after liver transplantation in rats. Am J Surg 2010, 199:35-42.
24. Hou Y.C., Chu C.C., Ko T.L., Yeh C.L., Yeh S.L. Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium. Eur J Nutr 2013, 52:1089-1098.
25. Beutheu S., Ouelaa W., Guérin C., Belmonte L., Aziz M., Tennoune N., et al. Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats. Clin Nutr 2013, published online Sept 26. 10.1016/j.clnu.2013.09.003.
26. Singleton K.D., Wischmeyer P.E. Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1839-R1845.
27. Hamiel C.R., Pinto S., Hau A., Wischmeyer P.E. Glutamine enhances heat shock protein 70 expression via increased hexosamine biosynthetic pathway activity. Am J Physiol Cell Physiol 2009, 297:1509-1519.
28. Wu G., Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem J 1998, 336:1-17.
29. Koppelmann T., Pollak Y., Mogilner J., Bejar J., Coran A.G., Sukhotnik I. Dietary l-arginine supplementation reduces methotrexate-induced intestinal mucosal injury in rat. BMC Gastroenterol 2012, 12:1-9.
30. Coburn L.A., Gong X., Singh K., Asim M., Scull B.P., Allaman M.M., et al. l-Arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS One 2012, 7.
31. Fan J., Meng Q., Guo G., Xie Y., Li X., Xiu Y., et al. Effects of early enteral nutrition supplemented with arginine on intestinal mucosal immunity in severely burned mice. Clin Nutr 2010, 29:124-130.
32. Katada K., Bihari A., Badhwar A., Yoshida N., Yoshikawa T., Potter R.F., et al. Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide. J Pharmacol Exp Ther 2009, 329:919-927.
33. Gobert A.P., Cheng Y., Akhtar M., Mersey B.D., Blumberg D.R., Cross R.K., et al. Protective role of arginase in a mouse model of colitis. J Immunol 2004, 173:2109-2117.
34. Koppelmann T., Pollak Y., Mogilner J., Bejar J., Coran A.G., Sukhotnik I. Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids. Br J Nutr 2013, 1:89-98.
35. Ibrahim A., Mbodji K., Hassan A., Aziz M., Boukhettala N., Coëffier M., et al. Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium. Clin Nutr 2011, 5:678-687.
36. Borniquel S., Jädert C., Lundberg J.O. Dietary conjugated linoleic acid activates PPARγ and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis. J Nutr 2012, 12:2135-2140.
37. Bassaganya-Riera J., Viladomiu M., Pedragosa M., DeSimone C., Hontecillas R. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One 2012, 7:34676.
38. Conley B.A., Egorin M.J., Tait N., Rosen D.M., Sausville E.A., Dover G., et al. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin Cancer Res 1998, 4:629-634.
39. Patnaik A., Rowinsky E.K., VilIalona M.A., Hammond L.A., Britten C.D., Siu L.L., et al. A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. Clin Cancer Res 2002, 8:2142-2148.
40. Hou Y., Wang L., Yi D., Ding B., Chen X., Wang Q., et al. Dietary supplementation with tributyrin alleviates intestinal injury in piglets challenged with intrarectal administration of acetic acid. Br J Nutr 2014, 10:1-11.
41. Hokari R., Matsunaga H., Miura S. Effect of dietary fat on intestinal inflammatory diseases. J Gastroenterol Hepatol 2013, 4:33-36.
42. Reynolds C.M., Loscher C.E., Moloney A.P., Roche H.M. Cis-9, trans-11-conjugated linoleic acid but not its precursor trans-vaccenic acid attenuate inflammatory markers in the human colonic epithelial cell line Caco-2. Br J Nutr 2008, 1:13-17.
43. Food and Agriculture Organization of the United Nations & World Health Organization (FAO/WHO) Guidelines for the evaluation of probiotics in food, food and agriculture organization of the united nations & world health organization working group report 2002, 1-11. London, Ontario, Canada.
44. Ueno N., Fujiya M., Segawa S., Nata T., Moriichi K., Tanabe H., et al. Heat-killed body of Lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. Inflamm Bowel Dis 2011, 17:2235-2250.
45. Shiou S.-R., Yu Y., Guo Y., He S.-M., Mziray-Andrew C.H., Hoenig J., et al. Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury. PLoS One 2013, 8:1-12.
46. Rao R.K., Samak G. Protection and restitution of gut barrier by probiotics: nutritional and clinical implications. Curr Nutr Food Sci 2013, 9:99-107.
47. Souza T.C., Zacarías M.F., Silva A.M., Binetti A., Reinheimer J., Nicoli J.R., et al. Cell viability and immunostimulating and protective capacities of Bifidobacterium longum 51A are differentially affected by technological variables in fermented milks. J Appl Microbiol 2012, 112:1184-1192.
48. Philippe D., Heupel E., Blum-Sperisen S., Riedel C.U. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis. Int J Food Microbiol 2011, 149:45-49.
49. Mennigen R., Nolte K., Rijcken E., Utech M., Loeffler B., Senninger N., et al. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009, 296:1140-1149.
50. Martins F.S., Vieira A.T., Elian S.D.A., Arantes R.M.E., Tiago F.C.P., Sousa L.P., et al. Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice. Microbes Infect 2013, 15:270-279.